APA (7th ed.) Citation

E, C., E, B., E, R., O, Z., J, E., O, L., & S, M. (2017). Sitagliptin ameliorates oxidative stress in experimental diabetic nephropathy by diminishing the miR-200a/Keap-1/Nrf2 antioxidant pathway. Dove Medical Press.

Chicago Style (17th ed.) Citation

E, Civantos, Bosch E, Ramirez E, Zhenyukh O, Egido J, Lorenzo O, and Mas S. Sitagliptin Ameliorates Oxidative Stress in Experimental Diabetic Nephropathy by Diminishing the MiR-200a/Keap-1/Nrf2 Antioxidant Pathway. Dove Medical Press, 2017.

MLA (8th ed.) Citation

E, Civantos, et al. Sitagliptin Ameliorates Oxidative Stress in Experimental Diabetic Nephropathy by Diminishing the MiR-200a/Keap-1/Nrf2 Antioxidant Pathway. Dove Medical Press, 2017.